1. Home
  2. SNSE vs PET Comparison

SNSE vs PET Comparison

Compare SNSE & PET Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SNSE
  • PET
  • Stock Information
  • Founded
  • SNSE 2005
  • PET 2015
  • Country
  • SNSE United States
  • PET United States
  • Employees
  • SNSE N/A
  • PET N/A
  • Industry
  • SNSE Biotechnology: Pharmaceutical Preparations
  • PET EDP Services
  • Sector
  • SNSE Health Care
  • PET Technology
  • Exchange
  • SNSE Nasdaq
  • PET Nasdaq
  • Market Cap
  • SNSE 12.3M
  • PET 10.7M
  • IPO Year
  • SNSE 2021
  • PET N/A
  • Fundamental
  • Price
  • SNSE $0.45
  • PET $0.21
  • Analyst Decision
  • SNSE Strong Buy
  • PET Strong Buy
  • Analyst Count
  • SNSE 3
  • PET 5
  • Target Price
  • SNSE $4.33
  • PET $4.40
  • AVG Volume (30 Days)
  • SNSE 330.7K
  • PET 6.6M
  • Earning Date
  • SNSE 11-14-2024
  • PET 02-12-2025
  • Dividend Yield
  • SNSE N/A
  • PET N/A
  • EPS Growth
  • SNSE N/A
  • PET N/A
  • EPS
  • SNSE N/A
  • PET N/A
  • Revenue
  • SNSE N/A
  • PET $76,747,000.00
  • Revenue This Year
  • SNSE N/A
  • PET N/A
  • Revenue Next Year
  • SNSE N/A
  • PET $13.90
  • P/E Ratio
  • SNSE N/A
  • PET N/A
  • Revenue Growth
  • SNSE N/A
  • PET N/A
  • 52 Week Low
  • SNSE $0.38
  • PET $0.14
  • 52 Week High
  • SNSE $1.94
  • PET $2.47
  • Technical
  • Relative Strength Index (RSI)
  • SNSE 47.08
  • PET 31.83
  • Support Level
  • SNSE $0.41
  • PET $0.20
  • Resistance Level
  • SNSE $0.50
  • PET $0.24
  • Average True Range (ATR)
  • SNSE 0.05
  • PET 0.02
  • MACD
  • SNSE -0.00
  • PET 0.02
  • Stochastic Oscillator
  • SNSE 34.09
  • PET 29.51

About SNSE Sensei Biotherapeutics Inc.

Sensei Biotherapeutics Inc is an immuno-oncology company focused on the discovery and development of next-generation therapeutics for cancer patients. Its TMAb (Tumor Microenvironment Activated Biologics) platform developing highly selective therapeutics designed to disable immunosuppressive signals or activate immunostimulatory signals selectively in the tumor microenvironment. The company have four investigational product candidates in various stages of development: SNS-101, SNS-102, SNS-103, SNS-20.

About PET Wag! Group Co.

Wag Group Co develops and supports a proprietary marketplace technology platform available as a website and mobile app that enables independent Pet Caregivers to connect with pet parents. The platform allows pet parents to make pet service requests in the platform, which can then be fulfilled by Pet Caregivers. Wag supports dog walking, pet sitting, pet boarding, drop-in visits at the pet parent's home, advice from licensed pet experts, training services, pet insurance comparison tools, and pet wellness plans.

Share on Social Networks: